NCT03338803View on ClinicalTrials.gov

Real World Glycemic Effectiveness of Linagliptin

CompletedOBSERVATIONAL
Enrollment

11,001

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

February 2, 2018

Study Completion Date

February 2, 2018

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Linagliptin

drug

Trial Locations (1)

55344

Optum, Eden Prairie

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY